Epidemiology of Chlamydia pneumoniae in atherosclerosis

American Heart Journal

Volumn 138, Issue 5 II, 1999, Pages

  Saikku, P ^a  

^a NONE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; IMMUNOGLOBULIN A ANTIBODY;

ANTIGEN ANTIBODY COMPLEX; ATHEROSCLEROSIS; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; HUMAN; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; SEROEPIDEMIOLOGY;

EID: 0032716118     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-8703(99)70285-1     Document Type: Conference Paper

References (38)

1. Grayston JT, Wang SP. History of Chlamydia pneumoniae (TWAR). In: Allegra L, Blasi F, editors. Chlamydia pneumoniae. The lung and the heart. Milano: Springer; 1999. p. 1-8.
2. Saikku P, Wang SP, Kleemola M, et al. An epidemic of mild pneumonia due to an unusual strain of Chlamydia psittaci. J Infect Dis 1985;151:832-9.
3. Aldous MB, Grayston JT, Wang SP, et al. Seroepidemiology of Chlamydia pneumoniae TWAR infection in Seattle Families, 1966-1979. J Infect Dis 1992;166:646-9.
4. Wang SP, Grayston JT. Population prevalence antibody to Chlamydia pneumoniae, strain TWAR. In: Bowie WR, Caldwell HD, Jone RP, et al, editors. Chlamydial infections. Cambridge: Cambridge University Press; 1990. p. 402-5.
5. Puolakkainen M, Kuo CC, Shor A, et al. Serological response to Chlamydia pneumoniae in adults with coronary arterial fatty streaks and fibrolipid plaques. J Clin Microbiol 1993;31:2212-4.
6. Juvonen J, Laurila A, Alakärppä H, et al. Demonstration of Chlamydia pneumoniae in the walls of abdominal aortic aneurysms. J Vasc Surg 1997;25:499-505.
7. Grayston JT, Golubjatnikov R, Hagiwara T, et al. Serologic tests for Chlamydia pneumoniae. Pediatr Infect Dis J 1993;11:790-1.
8. Saikku P. Chronic Chlamydia pneumoniae infections. In: Allegra L, Blasi F, editors. Chlamydia pneumoniae. The lung and the heart. Milan: Springer-Verlag; 1999. p. 96-113.
9. Saikku P, Leinonen M, Mattila K, et al. Serologic evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988;2:983-5.
10. Saikku P, Leinonen M, Tenkanen L, et al. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med 1992;116:273-8.
11. Miettinen H, Lehto S, Saikku P, et al. Association of Chlamydia pneumoniae and acute coronary heart disease events in non-insulin-dependent-diabetic and non-diabetic subjects in Finland. Eur Heart J 1996;17:682-8.
12. Ossewaarde JM, Feskens EJM, De Vries A, et al. Chlamydia pneumoniae is a risk factor for coronary heart disease in symptom-free elderly men, but Helicobacter pylori and cytomegalovirus are not. Epidemiol Infect 1998;120:93-9.
13. Davidson M, Kuo CC, Middaugh JP, et al. Confirmed previous infection with Chlamydia pneumoniae (TWAR) and its presence in early coronary atherosclerosis. Circulation 1998;98:628-33.
14. Patel P, Mendall MA, Carrington D, et al. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. Br Med J 1995;311:711-4.
15. Melnick SL, Shahar E, Folsom AR, et al. Past infection by Chlamydia pneumoniae strain TWAR and asymptomatic carotid atherosclerosis. Am J Med 1993;95:499-504.
16. Thom DH, Grayston JT, Siscovick DS, et al. Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. JAMA 1992;268:68-72.
17. Dahlén GH, Boman J, Birgander LS, et al. Lp(a) lipoprotein, IgG, IgA and IgM antibodies to Chlamydia pneumoniae and HLA class II genotype in early coronary artery disease. Atherosclerosis 1995;114:165-74.
18. Leinonen M, Linnanmäki E, Mattila K, et al. Circulating immune complexes containing chlamydial lipopolysaccharide in acute myocardial infarction. Microb Pathog 1990;9:67-73.
19. Linnanmäki E, Leinonen M, Mattila K, et al. Presence of Chlamydia pneumoniae specific antibodies in circulating immune complexes in coronary heart disease. Circulation 1993;87:1130-4.
20. Haidl S, Juul-Möller S, Israelsson B, et al. Ischemic heart disease and antibodies to Chlamydia pneumoniae (TWAR). Proc Eur Soc Chlamydia Res 2. Uppsala: Uppsala University Center for STD Research; 1992. p. 174
21. Blasi F, Consentini R, Raccanelli R, et al. A possible association of Chlamydia pneumoniae infection and acute myocardial infarction in patients younger than 65 years of age. Chest 1997; 112:309-12.
22. Thomas GN, Scheel O, Koehler AP, et al. Respiratory chlamydial infections in a Hong Kong teaching hospital and association with coronary heart disease. Scand J Infect Dis Suppl 1997;104:30-3.
23. th ICAAC, San Francisco, Sept 17-20, 1995. Washington DC: American Society for Microbiology; 1995. p. 340.
24. Mazzoli S, Tofani N, Fantini A, et al. Chlamydia pneumoniae antibody response in patients with acute myocardial infarction and their follow-up. Am Heart J 1998;135:15-20.
25. Perdikaris G, Mentis A, Makris TH, et al. Serologic response to Chlamydia pneumoniae (C. pneumoniae) in Greek adults with chronic coronary heart disease (CCHD) and acute myocardial infarction (AMI) (Preliminary report). Clin Infect Dis 1997;25:369.
26. Diedrichs H, Schneider CA, Scharkus S, et al. Prävalenz von Chlamydien-Antikörpern bei Patienten mit koronarer Herzerkrankung. Herz Kreislauf 1997;29:304-7.
27. Kark J, Leinonen M, Paltiel O, et al. Chlamydia pneumoniae and acute myocardial infarction in Jerusalem. Int J Epidemiol 1997;26:730-8.
28. th ICC, Sydney June 29-July 3, 1997, No. 3217, p. 82.
29. Mendall MA, Carrington D, Strachan D, et al. Chlamydia pneumoniae: Risk factors for seropositivity and association with coronary heart disease. J Infect 1995;30:121-8.
30. Weiss SM, Roblin PM, Gaydos CA, et al. Failure to detect Chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy. J Infect Dis 1996;173:957-62.
31. Wimmer M, Sandmann-Strupp R, Saikku P, et al. Association of chlamydial infection with cerebrovascular diseases. Stroke 1996;27:207-10.
32. Thom DH, Grayston JT, Siscovick DS, et al. Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. JAMA 1992;268:68-72.
33. Aceti A, Mazzacurati G, Amendolea MA, et al. H pylori and C pneumoniae infections may account for most acute coronary syndromes [letter]. BMJ 1996;313:428-9.
34. Cook PJ, Honeybourne D, Lip GYH, et al. Chlamydia pneumoniae and acute arterial thrombotic disease [letter]. Circulation 1995;92:3148.
35. th ECCMID, Vienna, 1995, No. 495, p. 95.
36. Miyashita N, Toyota E, Sawayama T, et al. Association of chronic infection of Chlamydia pneumoniae and coronary heart disease in the Japanese. Int Med 1998;37:913-6.
37. Lopes-Virella MF, Virella G. Immunological and microbiological factors in the pathogenesis of atherosclerosis. Clin Immunol Immunopathol 1985;37:377-8.
38. Holland SM, Taylor HR, Gaydos CA, et al. Experimental infection with Chlamydia pneumoniae in nonhuman primates. Infect Immun 1990;58:593-7.